Say goodbye to low-lying eyelids. Our Atlanta and Alpharetta offices now offers Upneeq. An FDA-approved prescription eyedrop for acquired blepharoptosis (also known as acquired ptosis or low-lying lids) in adults, proven to rapidly lift the upper eyelid.1,4.
What is Acquired Blepharoptosis?
Acquired ptosis (low-lying lids) is a common eyelid disorder that can impact adults of all ages. It can make eyes appear tired/sleepy/droopy or make on eyelid visibly lower than the other. And may cause vision impairment, interfering with day to day functions such as reading, driving and computer use.
If your eyes look “tired” or “sleepy” schedule an appointment to see if Upneeq is the right treatment for you.
LPFT=Leicester Peripheral Field Test (measuring superior visual field).
*Two randomized, multicenter, double-masked, vehicle-controlled, Phase 3 studies compared once-daily Upneeq in 304 subjects with acquired blepharoptosis. Efficacy was assessed with the Leicester Peripheral Field Test (LPFT) and photographic measurement of Marginal Reflex Distance (MRD-1). There was a statistically significant difference in mean change in the LPFT from baseline after instillation of Upneeq and vehicle, with significantly greater increases in the study eye of the Upneeq group evident at the 2-hour point and maintained at the 6-hour time point. Greater MRD-1 increases were observed for the Upneeq group than the vehicle group on Day 1 at 6 hours post-dose and on Day 14 at 2 hours post-dose.1
INDICATION
UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is indicated for the treatment of acquired blepharoptosis in adults.
IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
Adverse reactions that occurred in 1-5% of subjects treated with UPNEEQ were punctate keratitis, conjunctival hyperemia, dry eye, blurred vision, instillation site pain, eye irritation and headache.
DRUG INTERACTIONS
To report SUSPECTED ADVERSE REACTIONS or product complaints, contact RVL Pharmaceuticals at 1-877-482-3788. You may also report SUSPECTED ADVERSE REACTIONS to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
References: 1. Upneeq® (oxymetazoline hydrochloride ophthalmic solution) 0.1%. [Prescribing Information]. RVL Pharmaceuticals, Inc. 2020. 2. Finsterer J. Ptosis: causes, presentation, and management. Aesthetic Plast Surg. 2003;27(3):193-204. 3. Richards HS, Jenkinson E, Rumsey N,et al. The psychological well- being and appearance concerns of patients presenting with ptosis. Eye. 2014; 28(3):296-302. 4. Data on file, RVL Pharmaceuticals, Inc
Dr. Rudderman’s unique, integrated approach to plastic surgery employs only safe, effective, predictable surgical techniques that are driven by uncompromising respect for the natural condition of the human form. He understands that the body changes with time – as do desires. His primary goal is to deliver the best possible plastic surgery … specifically matched to each patient…in a safe environment with ultimate respect for every single individual…their concerns and goals. LEARN MORE »
“The best plastic surgery results must give each individual the opportunity to feel comfortable now and in the future…”
Dr. Randy Rudderman